Blog


Quantifying the Medicare Advantage advantage

July 25, 2018

In the 15 years since its inception, the increase in popularity of Medicare Advantage (MA) – health coverage provided by private plans in contrast to traditional fee-for-service (FFS) Medicare – … Continued


Action Needed for Market Stability, Access to Health Coverage

July 18, 2018

There is a consensus in this country that people who are struggling with illnesses and have a greater need for healthcare services should not be prevented from acquiring health insurance. … Continued


A Public Health Crisis Requires a Roadmap of Solutions

July 12, 2018

It’s indisputable that the opioid addiction crisis with which America is currently grappling is one of historic magnitude.  We’re losing more than 115 people per day from opioid overdoses.  Families … Continued


Addressing the Unintended Consequences of the Stark Law and Anti-Kickback Statute

October 12, 2016

In the new era of healthcare in which value-based care is steadily pushing aside the fee-for-service model, outdated rules and regulations continue to hinder the progress of healthcare reform. The … Continued


Let the Public Option Rest in Peace

August 24, 2016

Most will remember that one of the most spirited debates during congressional consideration of the Affordable Care Act, back in the early days of the Obama administration, concerned the proposed … Continued


Campaigns, Honesty and the Future of Medicare

August 17, 2016

It’s like a bad rerun, but one with real consequences.  Every two years, some political candidates and the interest groups that support them decide the best way to boost their … Continued


A Decade of Proving Critics Wrong

July 27, 2016

As it was enacted into law in 2003, the Medicare prescription drug benefit, which would come to be known as Medicare Part D, had no shortage of critics.  A New … Continued


An Innovation-Centric Approach to Pricing and Accessibility

July 7, 2016

“Policy should not lose sight of the fact that new treatments represent miracles to many patients, and should encourage more, not less innovation.” With those words in her op-ed in … Continued